Your cart

Your cart is empty


Not currently available

Adp Receptor Inhibitors - Clopidogrel (Paperback) Loot Price: R178 Discovery Miles 1 780
Adp Receptor Inhibitors - Clopidogrel (Paperback): Books Llc
Adp Receptor Inhibitors - Clopidogrel (Paperback): Books Llc

Share your images

Adp Receptor Inhibitors - Clopidogrel (Paperback)

Books Llc

 (sign in to rate)
Loot Price R178 Discovery Miles 1 780

Bookmark and Share

Supplier out of stock. If you add it to your wishlist we will send you an email should it become available again.

Chapters: Clopidogrel. Source: Wikipedia. Pages: 24. Not illustrated. Free updates online. Purchase includes a free trial membership in the publisher's book club where you can select from more than a million books without charge. Excerpt: Clopidogrel is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. The drug works by irreversibly inhibiting a receptor called P2Y12, an adenosine diphosphate ADP chemoreceptor. Adverse effects include hemorrhage, Severe neutropenia, and Thrombotic thrombocytopenic purpura (TTP). Clopidogrel is a pro-drug whose action may be related to an adenosine diphosphate (ADP) receptor on platelet cell membranes. The drug specifically and irreversibly inhibits the P2Y12 subtype of ADP receptor, which is important in aggregation of platelets and cross-linking by the protein fibrin. The blockade of this receptor inhibits platelet aggregation by blocking activation of the glycoprotein IIb/IIIa pathway. The IIb/IIIa complex functions as a receptor mainly for fibrinogen and vitronectin but also for fibronectin and von Willebrand factor. Activation of this receptor complex is the "final common pathway" for platelet aggregation, and is important in the cross-linking of platelets by fibrin. Platelet inhibition can be demonstrated two hours after a single dose of oral clopidogrel, but the onset of action is slow, so that a loading-dose of 300600mg is usually administered. Clopidogrel is indicated for: It is also used, along with aspirin, for the prevention of thrombosis after placement of intracoronary stent or as an alternative antiplatelet drug for patients who are intolerant to aspirin. International guidelines granted the highest grade of recommendation for NSTE-ACS, PCI and stent, for clopidogrel in addition to...More: http: //booksllc.net/?id=58797


Imprint: Books + Company
Country of origin: United States
Release date: September 2010
First published: September 2010
Editors: Books Llc
Dimensions: 152 x 229 x 2mm (L x W x T)
Format: Paperback - Trade
Pages: 26
ISBN-13: 978-1-156-37986-8
Barcode: 9781156379868
Categories: Books
LSN: 1-156-37986-5

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Loyalty partners